[A new quality of the therapy of anxiety and depression--escitalopram]

Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(2):79-84.
[Article in Russian]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Antidepressive Agents, Second-Generation / administration & dosage
  • Antidepressive Agents, Second-Generation / chemistry
  • Antidepressive Agents, Second-Generation / economics
  • Antidepressive Agents, Second-Generation / therapeutic use*
  • Anxiety / diagnosis
  • Anxiety / drug therapy*
  • Citalopram / administration & dosage
  • Citalopram / chemistry
  • Citalopram / economics
  • Citalopram / therapeutic use*
  • Data Interpretation, Statistical
  • Depression / diagnosis
  • Depression / drug therapy*
  • Disease Models, Animal
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged
  • Panic Disorder / diagnosis
  • Panic Disorder / drug therapy
  • Placebos
  • Primary Health Care
  • Randomized Controlled Trials as Topic
  • Recurrence
  • Selective Serotonin Reuptake Inhibitors / administration & dosage
  • Selective Serotonin Reuptake Inhibitors / chemistry
  • Selective Serotonin Reuptake Inhibitors / economics
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*
  • Stereoisomerism

Substances

  • Antidepressive Agents, Second-Generation
  • Citalopram
  • Placebos
  • Selective Serotonin Reuptake Inhibitors